The Medical Bulletin of Haseki publishes papers on all aspects of general medicine. In addition to original articles, review articles, original articles, case reports, letters to the editor and announcements of congress and meetings are also published. The scientific board guiding the selection of the papers to be published in the journal consists of elected experts of the journal and if necessary, is selected from national and international authorities.
Ethical committee approval may be requested by the Editor or Associate Editors for clinical research studies. Authors are responsible for the contents of the manuscripts and for the accuracy of the references.
The authors should guarantee that the manuscripts have not been previously published and/or are under consideration for publication elsewhere. Only those data presented at scientific meetings in form of abstract which do not exceed 200 words may be accepted for consideration, however, the date, name and place of the meeting in which the paper was presented should be stated. The signed statement of scientific contributions and responsibilities of all authors, and statement on the absence of conflict of interests are required. All manuscripts are reviewed by the editor, related associate editor and at least three experts/reviewers. The authors of the accepted for publication manuscripts should agree that the editor and the associate editors can make corrections on condition that there are no changes in the main text of the paper. Manuscript format should be in accordance with Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (available at http://www.icmje.org/)
The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.
The journal should be abbreviated as Med Bull Haseki when referenced.
The Medical Bulletin of Haseki does not charge any article submission or processing charges.
General Guidelines
Manuscripts are accepted only online and can be submitted electronically through web site (https://jag.journalagent.com/haseki/) after creating an account. This system allows online submission and review.
The ORCID (Open Researcher and Contributor ID) number of the correspondence author should be provided while sending the manuscript. A free registration can be done at http://orcid.org.
The manuscripts gathered with this system are archived according to ICMJE, Index Medicus (Medline/PubMed) and Ulakbim-Turkish Medicine Index Rules. Rejected manuscripts, except artworks are not returned.
Articles sent to the editor for publication should be written single-sided on A4 pages, double-spaced in 12-point, arial/times, new roman font and with 2.5 cm margins. Abbreviations must be explained clearly in parentheses in their first instance within the text and custom abbreviations should not be used. Numbers 1 to 10 should be given as text (In the two treatment groups ... the second day...) and numbers 11 or bigger given as numbers. However, numbers 1-10 with a descriptive suffix should be given with numbers (... 1 year) while numbers that start sentences (Fifteen-year-old female patient ...) should be given as text.
The manuscript should not exceed 5000 words in total. All pages of the manuscript should be numbered at the top right-hand corner, except for the title page. Papers should include the necessary number of tables and figures in order to provide better understanding.
The rules for the title page, references, figures and tables are valid for all types of articles published in this journal.
Patients have a right to privacy. When not essential, identifying information, patient names and photographs should not be published, unless the written informed consent of the patient (parent or guardian) has been given.
The patient should, therefore, be given a draft of the paper in order to obtain written informed consent. When not necessary, any identifying details of the patient should not be published. Complete anonymity is difficult to attain, however, informed consent should be obtained if any doubt exists. For example, masking the eye region of a patient’s photograph provides incomplete anonymity.
For the experimental, clinical and drug studies having the obligation of being approved by ethical committee and being sent in order to be published in The Medical Bulletin of Haseki, ethical committee approval report being in accordance with the international agreements with Helsinki Declaration revised 2013 is required (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights ("Guide for the Care and Use of Laboratory Animals" https://oacu.oir.nih.gov/regulations-standards) and they should obtain animal ethics committee approval. The approval of the ethical committee including approval number and the fact that the “informed consent” is given by the patients should be indicated in the “Methods” section. Authors should declare the conflict of interest concerning their articles and the financial supports.
Clinical Trial Policy
All clinical trials, which are any research projects that prospectively assign individuals or a group of people to an intervention, with or without concurrent comparison or control groups, in order to study the relationship between a health-related intervention and a health outcome, must be registered in a public trials registry acceptable to the International Committee of Medical Journals Editors (ICMJE). Authors of randomized controlled trials must adhere to the CONSORT guidelines and provide both a CONSORT checklist (for protocols, see the SPIRIT guidance) and flow diagram. For the flow chart, we require that you choose the MS Word template at www.consort-statement.org and cite/upload it in the manuscript as a figure. In addition, submitted manuscripts must include the unique registration number in the abstract as evidence of registration. Starting from August 2024, submitted manuscripts must include the unique registration number in the Abstract as evidence of registration.
You can register for clinical trials by visiting the following link:
Please click the following link to register the relevant record in the system and learn more about the required protocol:
https://classic.clinicaltrials.gov/ct2/manage-recs/how-register
Use of Large Language Models and Generative AI Tools
AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author
After reviewing the COPE statement, the editors of the Medical Bulletin of Haseki have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It's important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.
It is suggested that authors follow this format when preparing their statement:
During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].
Example:
During the preparation of this work, the author(s) utilized OpenAI's ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted the efficiency of literature review process and the comprehensiveness of the gathered research insights.
Original Articles
1) Title Page (Page 1): This page should include the titles of the manuscripts, information about the author(s), key words and running titles.
Keywords and running titles should also be included in the title page.
The names, affiliated institutions and full addresses of the authors should be given. The author to whom correspondence is to be addressed should be indicated separately. As e-mail addresses will be used preferentially for communication, the e-mail address of the corresponding author should be stated. In addition, telephone and fax numbers must be notified.
If the content of the paper has been presented before, and if the summary has been published, the time and place of the conference should be denoted on this page.
If any grants or other financial support has been given by any institutions or firms for the study, information must be provided by the authors.
2) Summary (Page 2): In the second page, summaries of the manuscripts (maximum 200 words for each) and the keywords should be given.
The Summary Should Consist of the Following Sub Sections: Aim, Methods, Results, Conclusion. Separate sections are not used in the summaries of the review articles, case reports and educational articles. For these articles, the summaries should not exceed 200 words and include the scope and aims of the study, the salient findings and conclusions.
The references should not be cited in the summary section. As far as possible, use of abbreviations are to be avoided. Any abbreviations used must be taken into consideration independently of the abbreviations used in the text.
3) Text (From the Page 3 or 4, according to the length of the summaries)
Please follow the instructions in “general guidelines.”
The Main Headings of the Text Should be as Follows: Introduction, Methods, Results, Discussion. Study Limitations and Conclusion
The introduction should include the rationale for investigation and the background of the present study. Results of the study should not be discussed in this part.
“Materials and methods” section should be presented in sufficient details to permit the repetition of the work. The statistical methods used should be clearly indicated.
Results should also be given in detail to allow the reproduction of the study.
The Discussion section should provide a correct and thorough interpretation of the results. The references should be directly related to the findings of the authors.
Study Limitation should be detailed in the section.
Conclusion section should provide highlighted and interpreted with the study's new and important findings.
Acknowledgements should be as brief as possible. Any support should be acknowledged in this section. (Acknowledgements should be only send with the Cover Page)
The excessive use of abbreviations is to be avoided. All abbreviations should be defined when first used by placing them in brackets after the full term. Abbreviations made in the abstract and in the text are taken into consideration separately. Abbreviations of the full terms stated in the abstract must be re-abbreviated after the same full term in the text.
4) References: Accuracy of reference data is the author's responsibility.
References should be numbered according to the consecutive citation in the text. References should be indicated in brackets in the text.
Personal communications, unpublished data and submitted manuscripts must be cited, not in this section, but in the text as "(name(s), unpublished data, 19…)."
The reference list should be typed on a separate page at the end of the manuscript. If there are more than 6 authors, abbreviation of “et al.” should be used for the authors out of the first three. Journal titles should be abbreviated according to the style used in the Index Medicus. All the references should be written according to the Vancouver system as follows:
a) Standard Journal Article: Intiso D, Santilli V, Grasso MG, Rossi R, Caruso I. Rehabilitation of walking with electromyographic biofeedback in foot-drop after stroke. Stroke. 1994;25:1189-92.
b) Book: Getzen TE. Health economics: fundamentals of funds. New York: John Wiley & Sons; 1997.
c) Chapter of a Book: Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk, CN: Appleton and Lange; 1995. p. 361-80.
If more than one editor: editors.
d) Conference Papers: Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10;Geneva, Switzerland: North-Holland; 1992. p. 1561-5.
e) Journal on the Internet:Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis. [serial online] 1995 1(1):[24 screens]. Available from:s URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed December 25, 1999.
f) Thesis:Kaplan SI. Post-hospital home health care: the elderly access and utilization (thesis). St. Louis (MO): Washington Univ; 1995.
5) Tables, Graphics, Figures and Pictures: All tables, graphics or figures should be numbered consecutively according to their place in the text and a brief descriptive caption should be given. Abbreviations used should be explained further in the figure’s legend. The text of tables especially should be easily understandable and should not repeat the data of the main text. Illustrations already published are acceptable if supplied by permission of the authors for publication. Figures should be done professionally and no grey colors should be used.
Special Sections
1) Reviews: All reviews within the scope of the journal will be taken into consideration by the editors; also the editors may solicit a review related to the scope of the journal from any specialist and experienced authority in the field.
2) Case Reports: Case reports should present important and rare clinical experiences. They should consist of the following parts: introduction, case, discussion.
3) Letters to the Editor: These are views about articles published in this journal. The editor may request responses to the letters. There are no separate sections in the text.
Correspondence
For all correspondence with the editorial board, mail or e-mail addresses given below may be used.
Editor of The Medical Bulletin of Haseki
University of Health Sciences Turkey, Istanbul Haseki Training and Research Hospital, Department of Nephrology Adnan Adivar Caddesi, 34906 Haseki-Aksaray, Istanbul, Turkey
Phone: +90 212 529 44 00/1874
Fax: +90 212 530 84 23
Web Page: www.hasekidergisi.com
E-mail: hasekidergisi@gmail.com
